SETD1A


Summary: The protein encoded by this gene is a component of a histone methyltransferase (HMT) complex that produces mono-, di-, and trimethylated histone H3 at Lys4. Trimethylation of histone H3 at lysine 4 (H3K4me3) is a chromatin modification known to generally mark the transcription start sites of active genes. The protein contains SET domains, a RNA recognition motif domain and is a member of the class V-like SAM-binding methyltransferase superfamily. [provided by RefSeq, Dec 2016].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in SETD1A


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IEA GO:0003723 RNA binding
MF IPI GO:0005515 protein binding
MF IDA GO:0008013 beta-catenin binding
MF IPI GO:0008134 transcription factor binding
MF TAS GO:0018024 histone-lysine N-methyltransferase activity
MF IDA GO:0042800 histone methyltransferase activity (H3-K4 specific)
Showing 1 to 6 of 20 rows rows per page

Gene expression in normal tissue: SETD1A

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 1

Gene-drug pathway distribution

Pathways in SETD1A


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa00310 Lysine degradation - Homo sapiens (human)
wikipathways WP2369 Histone Modifications
reactome R-HSA-212436 Generic Transcription Pathway
reactome R-HSA-3214841 PKMTs methylate histone lysines
reactome R-HSA-3247509 Chromatin modifying enzymes
reactome R-HSA-4839726 Chromatin organization
Showing 1 to 6 of 10 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in SETD1A

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​